Schrödinger is a physics-based computational platform opening new worlds of possibility for drug discovery and materials design through its industry-leading computational platform which is deployed by pharmaceutical, biotechnology, chemical, and electronics companies to accelerate R&D in both drug discovery and materials design. The Schrödinger platform revolutionizes discovery by enabling far broader exploration of chemical space and delivers better therapeutic candidates and higher-quality compounds far faster than traditional methods, at a lower cost, and with a higher probability of success. Schrödinger was formed in 1990 and is based in New York, New York.
